C. Silvander

发表

Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target.

Andrea Glasauer, A. Haegebarth, M. Quanz, 2017, ACS chemical biology.

Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design.

O. Fedorov, A. Talagas, K. Huber, 2018, Journal of medicinal chemistry.

Structural Basis for the Specificity of Human NUDT16 and Its Regulation by Inosine Monophosphate

P. Nordlund, S. Gräslund, T. Lundbäck, 2015, PloS one.

Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases.

P. Nordlund, Martin Hammarström, S. Gräslund, 2014, Structure.

Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase INPP5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family

P. Nordlund, B. Potter, G. Cozier, 2016, Biochemistry.

Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases.

P. Nordlund, Martin Hammarström, S. Gräslund, 2014, Structure.

Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target.

Andrea Glasauer, A. Haegebarth, M. Quanz, 2017, ACS chemical biology.

Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti‐tumor efficacy

A. Alexeyenko, B. Janji, S. Parpal, 2024, Molecular oncology.